Actinin alpha 3

First Platform for Massively Multiplexed Single-Cell In Situ Spatial Genomics Now Broadly Available to U.S. Market

Retrieved on: 
Tuesday, January 18, 2022

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    Through MERSCOPE, a one-of-a-kind single-cell spatial genomics platform technology, Vizgen is ushering in a new era in genomics.
  • We are working with our customers to bring new platform capabilities and applications throughout the year and continue to lead this new era of spatial genomics.
  • Vizgen is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single-cell spatial genomics, setting the standard for the spatial genomics field.
  • The company's MERSCOPETM Platform enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and unrivaled detection efficiency at subcellular resolution.